With a projected $20mil full year EBTDA EML is trading at a decent multiple for a MC of $400mil. I think many investors were turned off by the underwhelming growth in the last 2 qtrs, and the outlook for this coming quarter also may be slow. To maintain such a high multiple, I think many investors will want to see faster growth. It appears fund managers who know management have better knowledge of the company are fairly confident that these forecast deals will transpire, and its a matter of delayed execution. Thats re-assuring, and is what convinced me to buy today. Good news is that 90% plus seems to be re-curring revenue, and with a large cash position, this company seems fairly robust making it a safer long term hold in comparison to other companies in the small cap space.
An article in the Fool today: https://www.********.au/2018/02/21/why-the-eml-payments-ltd-share-price-is-down-21-today/
- Forums
- ASX - By Stock
- EML
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-28
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EML (ASX) to my watchlist
(20min delay)
|
|||||
Last
67.0¢ |
Change
-0.040(5.63%) |
Mkt cap ! $253.4M |
Open | High | Low | Value | Volume |
70.0¢ | 70.0¢ | 66.5¢ | $1.111M | 1.635M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 109155 | 66.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
67.0¢ | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 95155 | 0.665 |
10 | 178848 | 0.660 |
5 | 91592 | 0.655 |
11 | 114407 | 0.650 |
1 | 8646 | 0.645 |
Price($) | Vol. | No. |
---|---|---|
0.670 | 4999 | 1 |
0.675 | 8646 | 1 |
0.680 | 32439 | 3 |
0.685 | 9826 | 2 |
0.690 | 28646 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
EML (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online